High-dose glucocorticoid treatment induces rapid loss of trabecular bone mineral density and lean body mass

Osteoporosis International

Volumn 17, Issue 1, 2006, Pages 105-108

  Natsui, Koshi ^a   Tanaka, Kiyoshi ^b   Suda, Michio ^c   Yasoda, Akihiro ^d   Sakuma, Yoko ^d   Ozasa, Ami ^d   Ozaki, Shoichi ^e   Nakao, Kazuwa ^d  

^a FUKUI PREFECTURAL HOSPITAL   (Japan)

^b KYOTO WOMEN'S UNIVERSITY   (Japan)

^c KYOTO CITY HOSPITAL   (Japan)

^d KYOTO UNIVERSITY HOSPITAL   (Japan)

^e ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Body composition; Dual energy; Glucocorticoid induced osteoporosis; Lean body mass; Steroid myopathy; X ray absorptiometery

Indexed keywords

GLUCOCORTICOID;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FRACTURE; HUMAN; LEAN BODY WEIGHT; LUMBAR SPINE; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TRABECULAR BONE;

ADIPOSE TISSUE; ADULT; BODY COMPOSITION; BONE DENSITY; DENSITOMETRY, X-RAY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FEMUR NECK; GLUCOCORTICOIDS; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS;

EID: 29144463326     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-005-1923-3     Document Type: Article

References (15)

1. Saag KG, Koehnke R, Caldwell JR, Brasington R, Burmeister LF, Zimmerman B, Kohler JA, Furst DE (1994) Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med 96:115-123
2. van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C (2000) Use of oral corticosteroid and risk of fractures. J Bone Miner Res 15:993-1000
3. van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777-787
4. Wallach S, Cohen S, Reid DM, Hughes RA, Hosking DJ, Laan RF, Doherty SM, Maricic M, Rosen C, Brown J, Barton I, Chines AA (2000) Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Int 67:277-285
5. Kanda F, Okuda S, Matsushita T, Takatani K, Kimura KI, Chihara K (2001) Steroid myopathy: pathogenesis and effects of growth hormone and insulin-like growth factor-I administration. Horm Res 56:S24-S28
6. American College of Rheumatology Task Force on Osteoporosis Guidelines (1996) Recommendations for the prevention and treatment of glucocorticoid- induced osteoporosis. Arth Rheum 39:1791-1801
7. Pearson D, Miller CG (eds) (2002) Clinical trials in osteoporosis. Springer, Heidelberg Germany New York
8. Bonnick SL, Lewis LA (2002) Bone densitometry for technologists. Humana Press, Totowa, NJ
9. Canalis E, Giustina A (2001) Glucocorticoid-induced osteoporosis: summary of a workshop. J Clin Endocrinol Metab 86:5681-5685
10. Canalis E, Delany AM (2002). Mechanism of glucocorticoid action in bone. Ann NY Acad Sci 966:73-81
11. Luengo M, Picado C, Del Rio L, Guanabens N, Monsterrat JM, Setoain J (1991) Vertebral fractures in steroid dependent asthma and involutional osteoporosis. Thorax 46:803-806
12. Selby PL, Halsey JP, Adams KRH, Klimiuk P, Knight SM, Pal B, Stewart IM, Swinson DR (2000) Corticosteroids do not alter the threshold for vertebral fracture. J Bone Miner Res 15:952-956
13. Houtkooper LB, Going SB, Sproul J, Blew RM, Lohman TG (2000) Comparison of methods for assessing body-composition changes over 1 year in postmenopausal women. Am J Clin Nutr 72:401-406
14. Vestergaard P, Olsen ML, Paaske Johnsen S, Rejnmark L, Toft Sorensen H, Mosekilde L. (2003) J Intern Med 254:486-493
15. Bone and Tooth Society, National Osteoporosis Society, Royal College of Physicians. (2002) Glucocorticoid-induced osteoporosis: guidelines for prevention and treatment. Royal College of Physicians, London